BRAF and melanoma: Moreover, similar rates of BRAF mutations have been reported in various histological types of nevi (including congenital, intradermal, compound, and atypical ones) [45], suggesting that the activation of BRAF does not likely contribute to possible differences in the propensity to progression to melanoma among these nevi subsets.